Streetbeat News

Stock Prices

CMI

JP Morgan analyst Ann Duignan has downgraded Cummins (NYSE:CMI) from Neutral to Underweight and lowered the price target from $270 to $255.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:33 pm

AHG

Akso Health Group (NASDAQ:AHG) has regained compliance with Nasdaq's minimum bid price requirement. The company had previously received a notification for failing to maintain a minimum bid price of $1.00 over 30 consecutive business days. However, the closing bid price of the company's ADS was at $1.00 per share or greater from September 15, 2023 to October 10, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:32 pm

PWR

Quanta Services (NYSE:PWR) has outperformed the market over the past 15 years, producing an average annual return of 14.85%. If an investor had bought $100 of PWR stock 15 years ago, it would be worth $781.92 today.

Portfolio Pulse from Benzinga Insights

October 16, 2023 | 2:30 pm

DHR

Over the past 10 years, Danaher (NYSE:DHR) has outperformed the market by 6.24% on an annualized basis, producing an average annual return of 15.75%. If an investor had bought $1000 of DHR stock 10 years ago, it would be worth $4,335.70 today. Danaher currently has a market capitalization of $154.70 billion.

Portfolio Pulse from Benzinga Insights

October 16, 2023 | 2:30 pm

JD

Bernstein analyst Robin Zhu has downgraded JD.com from Outperform to Market Perform and lowered the price target from $55 to $31.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:30 pm

CCI

RBC Capital analyst Jonathan Atkin has downgraded Crown Castle (NYSE:CCI) from Outperform to Sector Perform and lowered the price target from $125 to $100.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:26 pm

WE

WeWork Inc (NYSE:WE) has appointed David Tolley as its CEO. Tolley has been a WeWork Board member since February 2023 and interim CEO since May 2023. The company is in the process of executing a strategic plan to reduce rent expenses and drive operational efficiency. WeWork's stock price, which had plummeted to less than $1 per share earlier in 2023, is now trading higher by 1.77% at $2.40.

Portfolio Pulse from Shivani Kumaresan

October 16, 2023 | 2:23 pm

AZN

AstraZeneca's supplemental New Drug Application for Tagrisso in combination with chemotherapy has been granted Priority Review by the FDA for locally advanced or metastatic non-small cell lung cancer (NSCLC). The FDA decision is expected in Q1 2024. The application is based on data from the FLAURA2 Phase 3 trial, which showed that the combination reduced the risk of disease progression or death by 38% compared to Tagrisso alone. AstraZeneca's shares are up 0.04% at $67.36.

Portfolio Pulse from Vandana Singh

October 16, 2023 | 2:20 pm

WHD

B of A Securities has downgraded Cactus (NYSE:WHD) from Neutral to Underperform, while raising the price target from $46 to $47.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:17 pm

MAXN

B of A Securities analyst Julien Dumoulin-Smith has downgraded Maxeon Solar Technologies (NASDAQ:MAXN) from Buy to Neutral and lowered the price target from $31 to $12.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:15 pm